Browsing: Heres
Here’s what it’s like to invest in private equity — and why you don’t want it in your 401(k)
It’s not just about risk and fees, but about knowing how much you have and having access to your money…
The Paramount-Skydance deal could open the door for a membership change, but Robinhood and AppLovin may once again miss out…
Royal Caribbean’s stock falls as a slight revenue miss and disappointing current-quarter outlook offset a profit beat and raised full-year…
NFL star Odell Beckham cheers bitcoin’s all-time high after taking his 2021 salary in the crypto. Here’s what it’s worth now.
“Safe to say we still happy with our decision,” Beckham says.
Netflix’s ‘Happy Gilmore 2,’ Hulu’s ‘It’s Always Sunny,’ Paramount’s ‘Star Trek: Strange New Worlds’ and Max’s streaming debut of ‘Sinners’…
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
Hims & Hers Health Inc.’s stock was headed for a record session of losses Monday after pharmaceutical giant Novo Nordisk,…
The launch of the EV maker’s robotaxi service caps a decade of promises about autonomous vehicles by Tesla CEO Elon…
Airo’s stock soared for a second straight day, even though the unprofitable drone maker’s IPO priced well below the expected…
Social Security’s new commissioner, rule reversals and cost cuts: Here’s everything that’s happening at the agency
A Social Security “war room,” threats to shut the agency, worker buyouts and a restraining order — here’s a timeline…
He spotted weight-loss drugs and AI before they became hot. Here’s this investor’s next big idea.
James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.